Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1324.50x is 269% above its 5-year average of -782.70x, near the high end of its 5-year range (-6433.22x–1508.93x).
579.99% above its 12-month average of -275.94x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2027 (2026-07-31): 1508.93x.
INTEREST COVERAGE RATIO
1324.50x
INTEREST COVERAGE RATIO AVG TTM
-275.94x
INTEREST COVERAGE RATIO AVG 3Y
-737.74x
INTEREST COVERAGE RATIO AVG 5Y
-782.70x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+579.99%
CURRENT VS 3Y AVG
+279.54%
CURRENT VS 5Y AVG
+269.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
+31635.71%
vs the sector median at left
Alzamend Neuro Inc
Market Cap
$5.36M
Interest Coverage Ratio
1324.50x
TTM Avg
-275.94x
3Y Avg
-737.74x
5Y Avg
-782.70x
Market Cap
$5.54M
Interest Coverage Ratio
-1174.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.81M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.26M
Interest Coverage Ratio
-10.70x
TTM Avg
10.43x
3Y Avg
9.52x
5Y Avg
9.52x
Market Cap
$4.85M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.19M
Interest Coverage Ratio
-310.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.36M | 1324.50x | -275.94x | -737.74x | -782.70x |
| Imunon, Inc. (IMNN)vs › | $5.21M | N/A | 1.00x | 1.02x | 1.02x |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | -1174.37x | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.81M | -2.90x | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.26M | -10.70x | 10.43x | 9.52x | 9.52x |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -16.26x | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | N/A | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.19M | -310.21x | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.29M | -1153.85x | N/A | N/A | N/A |
Interest Coverage
1324.5x
Debt/Equity
0.00
Current Ratio
3.01
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-31 | 1508.93x |
| 2026-04-30 | 219.35x |
| 2026-01-31 | -1643.72x |
| 2025-10-31 | -376.79x |
| 2025-07-31 | -1087.48x |
| 2025-04-30 | -2237.60x |
| 2025-01-31 | -513.83x |
| 2024-10-31 | -388.57x |
| 2024-07-31 | -80.16x |
| 2024-04-30 | -580.25x |
| 2024-01-31 | -1069.10x |
| 2023-10-31 | -673.10x |
| 2023-07-31 | -1921.49x |
| 2023-04-30 | -6368.03x |
| 2023-01-31 | -2630.22x |
| 2022-10-31 | -865.78x |
| 2022-07-31 | -1981.42x |
| 2022-04-30 | -6433.22x |
| 2022-01-31 | -156.85x |
| 2021-10-31 | -224.07x |
| 2021-07-31 | -169.23x |
| 2021-04-30 | -33.10x |
| 2021-01-31 | -17.00x |
| 2020-10-31 | -23.12x |
| 2020-07-31 | -8730.51x |
